Lb Pharmaceuticals (LBRX) Total Debt (2024 - 2026)

Lb Pharmaceuticals' Total Debt history runs 3 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Total Debt changed N/A year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (changed N/A YoY), while the FY2025 annual figure was $1.3 million, down 46.37% from the prior year.
• Total Debt was $1.1 million for Q1 2026 at Lb Pharmaceuticals, down from $1.3 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $2.5 million in Q4 2024 to a low of $942000.0 in Q3 2025.
• Historically, Total Debt has averaged $1.5 million across 3 years, with a median of $1.2 million in 2025.
• Biggest YoY gain for Total Debt was 46.37% in 2025; the steepest drop was 46.37% in 2025.
• A 3-year view of Total Debt shows it stood at $2.5 million in 2024, then plunged by 46.37% to $1.3 million in 2025, then declined by 14.89% to $1.1 million in 2026.
• The last three Total Debt figures came in at $1.1 million (Q1 2026), $1.3 million (Q4 2025), and $942000.0 (Q3 2025), per Business Quant data.